USFDA: New and Generic Drug Approvals: 28 OCT 2014

New and Generic Drug Approvals

October 28, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Adapalene adapalene Gel; Topical Actavis Mid Atlantic Approval
Carisoprodol carisoprodol Tablet;Oral Natco Pharma Ltd Approval
Darunavir Ethanolate darunavir ethanolate Tablet;Oral Hetero Labs Unit Iii Tentative Approval
Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride hydrocodone bitartrate;pseudoephedrine hydrochloride Solution;Oral Tris Pharma Inc Approval
Idkit:hp citric acid; urea c-13 For Solution, Tablet, For Solution;Oral Exalenz Bioscience Labeling Revision
Maraviroc maraviroc Tablet;Oral Hetero Labs Unit Iii Tentative Approval
Metoprolol Tartrate metoprolol tartrate Tablet;Oral Rubicon Research Pvt Ltd Approval
Nicardipine Hydrochloride nicardipine hydrochloride Injectable;Injection Exela Pharma Science Manufacturing Change or Addition
Quetiapine Fumarate quetiapine fumarate Tablet;Oral Alembic Pharms Ltd Approval
Sirolimus sirolimus Tablet; Oral Dr Reddys Labs Ltd Approval
Somatuline Depot lanreotide acetate Injectable;Subcutaneous Ipsen Pharma Manufacturing Change or Addition
Soriatane acitretin Capsule;Oral Stiefel Labs Inc Manufacturing Change or Addition
Vibramycin doxycycline hyclate Capsule;Oral Pfizer Manufacturing Change or Addition

No comments:

Post a Comment